All-cause mortality is the most important endpoint when evaluating cardiovascular medications like statins and PCSK9 inhibitors.

“what ultimately matters is all cause mortality I don't want to prescribe someone a Statin if they die sooner or at the same time of something else they may not die of cardiovascular disease but if I'm just shifting what they die of where is the benefit”